|
Years ago, just out of pharmacy school, I worked in a nursing home pharmacy where we supplied the oral and IV medications for several facilities. When we could not get an IV started in a patient we used a drug called hyaluronidase to increase absorption of the drug: then we could administer the IV drug under the skin. More recently this drug has been used to counteract improper injection or allergic reaction to hyaluronic acid by causing this acid to be broken down and absorbed into the body. Now Halozyme Therapeutics has applied hyaluronidase to improve control of post-prandial glucose levels in patients using rapid-acting insulin. To learn more, check out this Item #9, New Novel Approach Makes Insulin Response More Predictable, and also be sure to view the interview our publisher, Steve Freed, did with Halozyme's CEO, Dr. Gregory Frost.
During a discussion with our interns, we were talking about the potential problems patients with diabetes can expect with their kidneys. Our Mercer University Doctoral Candidate, Amanda Zell, has prepared a piece for you on the incidence of Kidney Stones and Diabetes.
******
Announcements:
The TCOYD Continuing Medical Education Program offers a unique opportunity to bridge patient and professional education, demonstrating the link between clinical lessons in the classroom to the real life patient experience. Find out more here.
Please answer this week's poll: Which factor most affects your blood glucose meter recommendations to patients?
*****************************
We can make a difference!
*****************************
Dave Joffe, Editor-in-chief |
